In March 2025, the company announced new designs for a direct-to-customer giving of its Wegovy weight loss drug. The company established a completely new pharmacy, referred to as NovoCare, which might demand clients $499 each month for use of the drug, a lot less than half the cost of the drug as a result of other pharmaceutical distribution networ